Myelodysplastic syndromes
MDS Patient & Family/Caregiver Forum in Houston, Texas
One of our partners, the MDS Foundation, Inc, is sponsoring another free MDS Patient & Family/Caregiver Forum. This event will be held in Houston, Texas When:
Rare Patient News. Well Done.
Positive Phase 2 Trial Results for Galactosemia Could Lead to Approval of New Therapy
- January 17, 2020
12 Healthcare Milestones that Defined the Decade
Can This Hormone That Regulates Sleep Treat Pulmonary Arterial Hypertension Symptoms?
Huntington’s Disease Patients Place Hopes in Clinical Trial
LATEST PATIENT WORTHY ARTICLES
Hemophilia
Gene Therapy is Shown to be Successful Treatment for Hemophilia A
Hemophilia A is the most common type of hemophilia, accounting for 8 of every 10 cases. Treatment in the past consisted of the administration
-300x300.jpg)
Caroli Disease
Leukemia Survivor Arranges Make-a-Wish Trip for a Young Caroli Disease Patient
Ty Eschenbaum’s world of high school football and working on his family’s ranch and farm changed suddenly after his freshman year when he was
Inflammatory Bowel Disease
IL-23 Inhibitors May be a Leading Treatment for Psoriasis and Psoriatic Arthritis
The 2019 European Academy of Dermatology and Venereology Congress was held in Madrid, Spain. During this conference, a symposium was held discussing IL-23 inhibition in
Multiple Sclerosis
Survey Illuminates Need to Provide Multiple Sclerosis Patients More Information
In the age of booming media, it can be difficult to know or be confident that you are receiving correct information. When it comes to
Rare Disease
Schizophrenia Patients in the United States Now Have a New Treatment Option
Schizophrenia patients in the United States now have a new treatment option. Intra-Cellular Therapies has just announced that their investigative therapy called CAPLYTA has received
